ATE334686T1 - Sphingomyelin enthaltende zusammensetzung zur verbesserung der tumortherapie - Google Patents

Sphingomyelin enthaltende zusammensetzung zur verbesserung der tumortherapie

Info

Publication number
ATE334686T1
ATE334686T1 AT00916269T AT00916269T ATE334686T1 AT E334686 T1 ATE334686 T1 AT E334686T1 AT 00916269 T AT00916269 T AT 00916269T AT 00916269 T AT00916269 T AT 00916269T AT E334686 T1 ATE334686 T1 AT E334686T1
Authority
AT
Austria
Prior art keywords
tumor therapy
improvement
sphingomyelin
composition containing
containing sphingomyelin
Prior art date
Application number
AT00916269T
Other languages
English (en)
Inventor
David Modrak
Original Assignee
Ct Molecular Med & Immunology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ct Molecular Med & Immunology filed Critical Ct Molecular Med & Immunology
Application granted granted Critical
Publication of ATE334686T1 publication Critical patent/ATE334686T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/688—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols both hydroxy compounds having nitrogen atoms, e.g. sphingomyelins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT00916269T 1999-03-25 2000-03-24 Sphingomyelin enthaltende zusammensetzung zur verbesserung der tumortherapie ATE334686T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12618999P 1999-03-25 1999-03-25

Publications (1)

Publication Number Publication Date
ATE334686T1 true ATE334686T1 (de) 2006-08-15

Family

ID=22423475

Family Applications (2)

Application Number Title Priority Date Filing Date
AT06075201T ATE512664T1 (de) 1999-03-25 2000-03-24 Sphingomyelin enthaltende zusammensetzung zur behandlung der rheumatoiden arthritis
AT00916269T ATE334686T1 (de) 1999-03-25 2000-03-24 Sphingomyelin enthaltende zusammensetzung zur verbesserung der tumortherapie

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT06075201T ATE512664T1 (de) 1999-03-25 2000-03-24 Sphingomyelin enthaltende zusammensetzung zur behandlung der rheumatoiden arthritis

Country Status (9)

Country Link
US (2) US6541462B1 (de)
EP (2) EP1165137B1 (de)
JP (1) JP2002540172A (de)
AT (2) ATE512664T1 (de)
AU (1) AU3740000A (de)
CA (2) CA2368676C (de)
DE (1) DE60029762T2 (de)
ES (1) ES2269121T3 (de)
WO (1) WO2000057916A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7683044B2 (en) * 1999-03-25 2010-03-23 Center For Molecular Medicine And Immunology Sphingomyelin therapy of autoimmune disease
EP1165137B1 (de) * 1999-03-25 2006-08-02 Center For Molecular Medicine And Immunology Sphingomyelin enthaltende zusammensetzung zur verbesserung der tumortherapie
WO2007034927A1 (ja) * 2005-09-22 2007-03-29 Snow Brand Milk Products Co., Ltd. スフィンゴミエリン含有医薬、飲食品または飼料
US9056129B2 (en) * 2007-02-09 2015-06-16 Northeastern University Precision-guided nanoparticle systems for drug delivery
ES2824074T3 (es) 2013-01-24 2021-05-11 Memorial Sloan Kettering Cancer Center Método para diagnosticar o tratar tumores mediante el uso de liposomas que contienen esfingomielina
US9851358B2 (en) * 2014-01-08 2017-12-26 Inserm (Institut National De La Sante Et De La Recherche Medicale) Methods and pharmaceutical compositions for preventing or reducing metastatic dissemination
GB201414464D0 (en) * 2014-08-14 2014-10-01 Technion Res & Dev Foundation Compositions and methods for therapeutics prescreening

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5859912A (ja) * 1981-10-06 1983-04-09 Green Cross Corp:The 鎮痛消炎物質脂肪乳剤
WO1995021175A1 (en) 1994-02-02 1995-08-10 The Liposome Company, Inc. Pharmaceutically active compounds and liposomes, and methods of use therof
US5543152A (en) * 1994-06-20 1996-08-06 Inex Pharmaceuticals Corporation Sphingosomes for enhanced drug delivery
US5800833A (en) * 1995-02-27 1998-09-01 University Of British Columbia Method for loading lipid vesicles
WO1997024112A1 (fr) * 1995-12-28 1997-07-10 Yoshitomi Pharmaceutical Industries, Ltd. Preparation a usage externe
US6372714B1 (en) * 1997-04-07 2002-04-16 Daiichi Pharmaceutical Co., Ltd. Composition for gene introduction into cell
EP1165137B1 (de) * 1999-03-25 2006-08-02 Center For Molecular Medicine And Immunology Sphingomyelin enthaltende zusammensetzung zur verbesserung der tumortherapie

Also Published As

Publication number Publication date
AU3740000A (en) 2000-10-16
JP2002540172A (ja) 2002-11-26
CA2707691C (en) 2013-09-03
CA2368676C (en) 2010-09-07
EP1165137B1 (de) 2006-08-02
EP1666045B1 (de) 2011-06-15
WO2000057916A1 (en) 2000-10-05
DE60029762T2 (de) 2007-10-18
DE60029762D1 (de) 2006-09-14
US7288534B2 (en) 2007-10-30
US20030228257A1 (en) 2003-12-11
EP1666045A1 (de) 2006-06-07
US6541462B1 (en) 2003-04-01
CA2368676A1 (en) 2000-10-05
CA2707691A1 (en) 2000-10-05
ES2269121T3 (es) 2007-04-01
EP1165137A1 (de) 2002-01-02
ATE512664T1 (de) 2011-07-15

Similar Documents

Publication Publication Date Title
ID26956A (id) Pencegahan raf kinase menggunakan simetris dan nonsimetris yang digantikan diphenil urea
DE69839682D1 (de) Pharmazeutische Zusammensetzungen enthaltend Arsentrioxid zur Behandlung von nicht-Hodgkihn-Lymphome
ATE312103T1 (de) Substituierte porphyrine und deren therapeutische verwendungen
DK0612248T3 (da) Præparat, der indeholder cisplatin og topotecan som antitumormiddel
MX9101913A (es) Derivados de quinazolinas para potenciar la actividad antitumoral
JO2373B1 (en) W-carboxy-aryl diphenyl urease substitutes used as RAV inhibitors
DE50310516D1 (de) Fredericamycin-derivate
HK1060067A1 (en) Compositions for antitumour treatment containing ecteinascidin 743
DE502004002571D1 (de) Substituierte 3-pyrrolidin-indol-derivate
WO2000018439A3 (de) Verwendung von neoangiogenese-markern für diagnose und therapie von tumoren
DK0944389T3 (da) Oprensede sammensætninger af 10-propargyl-10-deazaaminopterin og fremgangsmåder til anvendelse deraf i behandlingen af tumorer
SE0102147D0 (sv) New methods
ATE334686T1 (de) Sphingomyelin enthaltende zusammensetzung zur verbesserung der tumortherapie
ATE298339T1 (de) ß3,7-DIAZABICYCLO(3.3.0)OCTANE UND DEREN VERWENDUNG BEI DER BEHANDLUNG VON HERZRHYTHMUSSTÖRUNGENß
ATE334589T1 (de) Anti-arrhythmische zusammensetzungen und behandlungsverfahren
NO983177L (no) Anvendelse av 1-enantiomeren av centkroman til fremstilling av et farmasaytisk preparat for behandling eller profylakse av brystkreft
RU94040886A (ru) Применение производных мелатонина для лечения нарушений сна, фармацевтическая композиция
TR199901782T2 (xx) Migren tedavisi i�in ibuprofen ve domperidon ihtiva eden farmas�tik bile�imler.
KR960700734A (ko) 사람 암에 대한 시스플래틴/타목시펜 배합 치료(Combination cisplatin/tamoxifen therapy for human cancers)
DE3462688D1 (en) 1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane useful in combating diseases
JO2199B1 (en) Replaced pyrrols
ATE428418T1 (de) Mit einem serotonin-transporter zusammenwirkende mittel zur krebsbehandlung
DE60221104D1 (de) Substituierte diarylharnstoffe als stimulatoren der fas-vermittelten apoptose
TR200200987T2 (tr) Kanser tedavisine yönelik,ornatılmış pirroller
ATE537838T1 (de) Kombinationstherapie mit kloretazin(tm)

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties